IL6 and cancer: However, trans-signaling is an alternative to the classic IL-6 signaling pathway and allows for the modulation of functions of a wide range of target cells (including cancer cells, neurons, or osteoclasts that do not have the membrane-bound receptor composed of alpha and beta subunits).